British drugmaker GSK is preparing for potential new U.S. tariffs on its medicines and can handle the challenge, the company’s leader said Wednesday. “I would say we’ve been preparing, we ...

The House Judiciary Committee is looking into a tip that GSK brought to federal prosecutors in New York shortly after President Donald Trump won his second U.S. presidential election last fall ...

GSK has made a new drug submission (NDS) to Health Canada for the monoclonal antibody, depemokimab, targeting two specific conditions. The first proposed indication is for the use as an add-on ...

PENMENVY, recently approved by the U.S. Food and Drug Administration (FDA) for use in individuals aged 10 to 25, offers broad coverage in a single dose. This means adolescents can now be protected ...